LOADING

Blue biotech can unlock ‘considerable’ marine raw material potential: Experts

Using biotechnology to extract marine compounds holds huge potential for sustainable cosmetics, but the market remains largely unexploited and faces considerable hurdles, say experts.  

More

Smart Money Is Racing Into the Biotech Boom

The biotech boom is back. After its big breakthrough a few years ago, the biotech industry fell silent. Now, it is in the spotlight once again as smart money races in to back some once-in-a-generation..

More

NIAB develops device to detect Covid in 30 seconds

Researchers from Hyderabad- based National Institute of Animal Biotechnology (NIAB) reported the development of a non-invasive biosensor testing device, named ‘eCovSens’, for rapid detection of Covid-..

More

Gurgaon-based Premas Biotech enters COVID-19 vaccine race with triple antigen vaccine

Gurgoan-based biotech Premas Biotech is the latest entrant into the COVID-19 vaccine race. Unlike single-protein vaccines currently under trials across the world, Premas Biotech is developing a multi..

More
Gurgaon-based Premas Biotech enters COVID-19 vaccine race with triple antigen vaccine

Gurgoan-based biotech Premas Biotech is the latest entrant into the COVID-19 vaccine race. Unlike single-protein vaccines currently under trials across the world, Premas Biotech is developing a multi..

More
Bengaluru-based biotech firm Genei Laboratories to produce IIT-Delhi's COVID-19 testing kit

IIT-Delhi's low-cost COVID-19 testing kit will be produced by a Bengaluru-based biotechnology firm and is expected to be available by the first week of June, according to officials.

More
Coronavirus: $100k for Wellington biotech company to secure Covid-19 vaccine supply

A Wellington-based biotech company has been awarded $100,000 to start looking at the security of supply of a coronavirus vaccine in New Zealand.  

More
Coronavirus: China’s Sinovac Biotech in talks to test Covid-19 vaccine globally

Sinovac Biotech is in discussion with regulators in other countries, and the WHO, to launch phase III clinical trials in regions where the novel coronavirus is still spreading rapidly, CEO Yin Weidong..

More